- Home
- NKTR vs NUW Comparison
NKTR vs NUW Comparison
Compare NKTR & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- NUW
- Stock Information
- Founded
- NKTR 1990
- NUW 2008
- Country
- NKTR United States
- NUW United States
- Employees
- NKTR N/A
- NUW N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- NUW Investment Managers
- Sector
- NKTR Health Care
- NUW Finance
- Exchange
- NKTR Nasdaq
- NUW Nasdaq
- Market Cap
- NKTR 108.3M
- NUW 245.0M
- IPO Year
- NKTR 1994
- NUW N/A
- Fundamental
- Price
- NKTR $23.01
- NUW $13.70
- Analyst Decision
- NKTR Strong Buy
- NUW
- Analyst Count
- NKTR 6
- NUW 0
- Target Price
- NKTR $81.67
- NUW N/A
- AVG Volume (30 Days)
- NKTR 4.7M
- NUW 45.3K
- Earning Date
- NKTR 08-07-2025
- NUW 01-01-0001
- Dividend Yield
- NKTR N/A
- NUW 3.66%
- EPS Growth
- NKTR N/A
- NUW N/A
- EPS
- NKTR N/A
- NUW N/A
- Revenue
- NKTR $87,248,000.00
- NUW N/A
- Revenue This Year
- NKTR N/A
- NUW N/A
- Revenue Next Year
- NKTR N/A
- NUW N/A
- P/E Ratio
- NKTR N/A
- NUW N/A
- Revenue Growth
- NKTR N/A
- NUW N/A
- 52 Week Low
- NKTR $6.48
- NUW $12.45
- 52 Week High
- NKTR $37.38
- NUW $14.44
- Technical
- Relative Strength Index (RSI)
- NKTR 62.47
- NUW 54.97
- Support Level
- NKTR $21.87
- NUW $13.64
- Resistance Level
- NKTR $26.59
- NUW $13.85
- Average True Range (ATR)
- NKTR 3.84
- NUW 0.10
- MACD
- NKTR 0.21
- NUW 0.01
- Stochastic Oscillator
- NKTR 50.64
- NUW 51.61
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.